Radiopharm Theranostics Files 6-K for August 2025
Ticker: RDPTF · Form: 6-K · Filed: Aug 1, 2025 · CIK: 1949257
| Field | Detail |
|---|---|
| Company | Radiopharm Theranostics Ltd (RDPTF) |
| Form Type | 6-K |
| Filed Date | Aug 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, foreign-private-issuer, regulatory-filing
TL;DR
Radiopharm Theranostics filed a 6-K for August 2025, confirming its foreign private issuer status and 20-F reporting.
AI Summary
Radiopharm Theranostics Limited filed a Form 6-K on August 1, 2025, reporting information for the month of August 2025. The filing indicates the company is a foreign private issuer and will file annual reports under Form 20-F. The principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
Why It Matters
This filing provides routine updates for investors and regulators regarding Radiopharm Theranostics' status as a foreign private issuer and its reporting obligations.
Risk Assessment
Risk Level: low — This is a routine administrative filing by a foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- Radiopharm Theranostics Limited (company) — Registrant
- 001-41621 (company) — SEC File Number
- Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (company) — Principal executive office address
- Form 20-F (company) — Annual report form
- Form 6-K (company) — Filing type
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information to the SEC.
What is Radiopharm Theranostics Limited's SEC file number?
Radiopharm Theranostics Limited's SEC file number is 001-41621.
Does Radiopharm Theranostics file annual reports under Form 20-F or 40-F?
Radiopharm Theranostics indicates it files annual reports under cover of Form 20-F.
Where is Radiopharm Theranostics Limited's principal executive office located?
The principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
Is Radiopharm Theranostics providing information under Rule 12g3-2(b)?
No, the registrant indicated 'No' for furnishing information pursuant to Rule 12g3-2(b).
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on August 1, 2025 regarding Radiopharm Theranostics Ltd (RDPTF).